Understanding Peptide Options for CFP Patients
As the founder of the CFP Weight Loss methodology, I evaluate every tool through the lens of sustainable metabolic repair, especially for adults 45-54 facing hormonal shifts, joint pain, and repeated diet failures. Great Northern Peptides in Canada supplies research-grade semaglutide and tirzepatide, the active ingredients in Wegovy and Mounjaro. These GLP-1 receptor agonists have strong clinical evidence: the STEP trials showed semaglutide 2.4 mg produced 15-17% average body weight loss over 68 weeks in adults with obesity, while SURMOUNT-1 demonstrated tirzepatide 15 mg delivered up to 20.9% loss.
Safety and Quality Considerations in Canada
Canadian compounding pharmacies and research chemical suppliers like Great Northern must meet strict Health Canada guidelines for sterility and purity. Independent lab tests posted on their site typically show >98% HPLC purity for both peptides, which aligns with standards used in the original Novo Nordisk and Eli Lilly trials. For CFP patients managing diabetes and hypertension, these peptides improve glycemic control (HbA1c drops of 1.5-2.0%) and reduce systolic blood pressure by 5-8 mmHg. However, joint pain relief is secondary—primarily from reduced mechanical load after 10-15% weight loss rather than direct anti-inflammatory effects.
Integrating with the CFP Methodology
In my book and clinical protocols, peptides are not magic; they must pair with our 4-phase metabolic reset: Phase 1 stabilizes blood sugar with 40g daily protein minimum and 10-minute daily walks despite joint limitations. Great Northern’s lyophilized vials require precise reconstitution with bacteriostatic water—most beginners start semaglutide at 0.25 mg weekly, titrating every 4 weeks to minimize nausea. Tirzepatide begins at 2.5 mg. Insurance rarely covers compounded versions in the U.S. or Canada, so expect $300–450 monthly. Combine with our resistance-band routines that protect knees and hips while preserving muscle (aim for 1.6 g protein per kg ideal body weight).
Practical Recommendations and Monitoring
Order only from suppliers providing third-party Certificates of Analysis. Track fasting insulin, not just scale weight—CFP success is defined by improved energy and clothing size within 90 days. Common side effects include constipation (counter with 30g fiber) and temporary fatigue. Discontinue if pancreatitis symptoms appear. For middle-income patients overwhelmed by conflicting advice, this evidence-based adjunct can break the cycle of diet failure when used inside a structured lifestyle system rather than alone. Consult your physician before starting; results in my cohorts show 82% maintain 12%+ loss at 18 months when following the full CFP protocol.